22 May 2013
Keywords: australia, oks, shire, solaraze, ak, uk-based, drugmaker
Article | 11 December 2006
UK-based drugmaker Shire says that the Australian Department of Health and Aging at the Therapeutic Goods Administration (TGA) has approved
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 December 2006
27 November 2006
21 May 2013
© 2013 thepharmaletter.com